Equities Q&A with CEO of Eyecarrot Innovations Corp (EYC), Adam Cegielski

Equities had a far reaching informational Q&A with Adam Cegielski, CEO of Eye Carrot (TSX.V: EYC) we learned about his plan for 2016 and beyond.

Q.) Your website suggests traditional focus on vision problems, such as visual acuity, the sharpness of vision, is incomplete. For those not expert in the field, can you speak about some deeper issues affecting vision?

A.)Sure. Traditional vision care in the modern world is largely dominated by prescribing lenses and frames to address visual acuity. It’s a very easy process to measure how clearly you see, and then sell products based on that clarity. Also, primary care and vision in general has been focused on disease and pathology. There’s a tremendous amount that can be done to actually enhance your vision and how your vision system performs. What we’re talking about is the functional vision system; how your visual system reacts to stimuli in its environment. We want to do a deeper evaluation of how you measure this visual system, and how you train that visual system to get better performance.

Q.) Why is the other 90% of visual performance spectrum not addressed?

A.) Traditionally, it has been complicated. It’s been difficult to understand. It also takes a little bit longer than the 10-15 minutes insurance companies and government give doctors to do a complete check-up on the visual system. We’re trying to identify these problems quicker, make it easier for doctors to prescribe activities, allow doctors and patients to work together in the treatment of the visual system, and refer to a specialist if necessary.

Q.) Recent research demonstrated that some people with reading disabilities have deficits with their transmission of information to the brain through defective visual pathways. It appears to reinforce the outdated approach of focusing exclusively on visual acuity as your site suggests. How does Binovi fit within this assessment, and as a patient using Binovi, what are the physiological affects improving vision? What’s happening inside the body improving vision?

A.) Great. There is a ton of research that has come out addressing this issue. You can have 20/20 vision and still fail a functional vision exam. You can have a concussion and have 20/20 vision, but still have visual processing deficits. When you look at the education system, we screen kids to see if they have 20/20 vision, yet, 5 out of the 9 symptoms of ADHD are the same as the vision processing issue that we’re talking about. What the world needs is a combination of quicker and easier ways to screen for visual processing deficiencies or issues, and, more importantly, a simple and effective way to treat these issues to help people live happier, healthier lives.

So that’s why we built Binovi. We’re starting with the treatment side first – we want to streamline this and make it really easy for every qualified doctor and therapist, to treat these problems instead of resorting to things like prescription drugs.And make it really easy for them to refer patients to specialists or experts in our network if needed. We’re really excited to be releasing our Binovi apps in the coming weeks. And soon, we’ll have some exciting news to share on the screening front – we’ve been working on integrated hardware and software components to make screening for visual processing disorders quick, easy and scalable.

From a physiological standpoint, we’re trying to tie the action system of the body to the visual system. It’s one thing to see clearly, but do you know how to act on what you see? How can you grasp the information from a book if you have double vision? We want to help people identify they have this problem, and get that treatment process started quickly. Ultimately, we’re trying to do sensory motor integration; tying the visual senses and the cognitive functions to the action senses.

Q.) The company’s focus is on vision, but Binovi appears to have broader applications, for example, Alzheimer’s. Is there an opportunity to license this technology?

A.) Our focus is obviously on vision, but it’s important to realize that the visual system istied to the brain, and the brain is tied to various other systems. Whether we’re talking about other verticals like balance, brain, general health, fitness, and aging, there is a ton of research on how our technology can positively impactall sorts of different verticals. We’re happy to explore options to license our platform andtechnology to all sorts of organizations that will benefit from our world class team and library.

Q.) Is there anything else you’d like to add?

A.) We’re just excited about the progress we’ve made in 2016 and getting our apps live in the App Store. We expect to be on-boarding the first group of doctors over the next 2-4 weeks, and they’ll be going live with our product immediately. We’ll be targeting international markets in their local languages in the spring time frame.

In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.